Two-year cancer-DNA-fragment screening blood test trial to start in England to assess sensitivity and specificity of early detection of numerous cancer types. If successful, it could lead to treatment of once difficult-to-detect early cancers.
Medical Mythbusting Commentary for September 20, 2021
Two-year Cancer DNA fragment screening blood test trial to start in England to assess sensitivity and specificity in early detection of numerous cancer types. If successful, it could lead to treatment of difficult-to-detect early cancers.Play Now | Play in Popup | Download